Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

ByThe Short Paper

This study tested a new treatment called mezigdomide, combined with dexamethasone, for people with multiple myeloma (a type of cancer). The treatment showed promise in patients who had already tried other treatments, including those resistant to lenalidomide and pomalidomide.

In the first phase of the study, they tested the treatment on 77 patients to determine the right dose and schedule and to check for side effects. The most common side effects were problems with the blood (neutropenia) and infections. Based on these results, they decided on the best dose and schedule for the next phase.

In the second phase, 101 patients received the treatment identified in the first phase. These patients had very advanced myeloma and had often tried other treatments, including anti-BCMA therapy. The most common side effects were blood problems and infections, but they were mostly reversible. The treatment led to an overall response in 41% of patients, with a median duration of response of 7.6 months.

In conclusion, the combination of mezigdomide and dexamethasone showed promise in patients with advanced multiple myeloma, with mainly manageable side effects.

Similar Posts

Simple Summary – Transfusion Volume for Children with Severe Anemia in Africa

ByThe Short Paper

Link to the article: https://www.nejm.org/doi/full/10.1056/NEJMoa1900100?query=featured_home Similar to the last article, it’s been known that the WHO has specific transfusion guidelines which parts of Africa follows. In patients with severe anemia, red blood cells are transfused at a flat rate of 20 ml per kilogram of body weight. Although this transfusion rate is not in line with…

Simple Summary – C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations

ByThe Short Paper

Link to the article: https://www.nejm.org/doi/full/10.1056/NEJMoa1803185 This study revolves around the usage of a point of care test to guide antibiotic usage in patients with chronic obstructive pulmonary disease (COPD). They tested C-reactive protein (CRP) in patients with COPD. CRP is a inflammatory marker and increased levels are associated with worsening COPD. The study had two groups…

Sedentary Behavior and Incident Dementia Among Older Adults

ByThe Short Paper

This study examined whether sitting for long periods, known as sedentary behavior, is linked to the development of dementia in older adults. They collected data from over 49,000 adults aged 60 or older who did not have dementia at the beginning of the study. The results showed that spending more time sitting was associated with…

Simple Summary – Association of Egg Intake With Blood Lipids, Cardiovascular Disease, and Mortality in 177,000 People in 50 Countries

ByThe Short Paper

Link to the article: https://pubmed.ncbi.nlm.nih.gov/31965140/ The study looked at 146,011 people from 21 countries. Egg consumption was recorded using food frequency questionaire. They looked a the hazard ratios of those people and found no association with egg consumption and blood lipids, mortality, or major cardiovascular events. TL;DR Eggs aren’t associated with increased health complications (CVD, blood…

Simple Summary – Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

ByThe Short Paper

Link to the article: https://www.nejm.org/doi/full/10.1056/NEJMoa1817073 There is a standard of care in the treatment of chronic lymphocytic leukemia (CLL), a blood cancer common in the older population. The standard of care is the usage of fludarabine, cyclophosphamide, and rituximab; however there is a new treatment that may improve outcomes. This study looks at the usage of ibrutinib-rituximab….

An mRNA Vaccine against SARS-CoV-2 – Preliminary Report

ByThe Short Paper

Article This was a phase 1 trial where they tested an mRNA vaccine on 45 patients ages 18 to 55 years old. There were 3 different dose groups, n=15. Each dose group received a total of 2 vaccinations 28 days apart. They found dose appropriate anti-SARS-CoV-2 titer increases. There were some minor side effects “fatigue, chills,…